VolitionRx Limited

AMEX: VNRX · Real-Time Price · USD
0.68
0.04 (5.62%)
At close: Aug 15, 2025, 3:59 PM
0.69
1.34%
After-hours: Aug 15, 2025, 07:45 PM EDT

VolitionRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.31M 1.23M 1.29M 976.52K 797.03K 775.3K 651.04K 518.55K 341.99K 306.39K 200.92K 193.69K 178.72K 90.03K 82.92K 58.01K 38.42K
Cost of Revenue
n/a n/a 362.92K 725.38K 1.08M 1.08M 1.02M 659.5K 307.83K 307.83K n/a n/a n/a n/a n/a n/a 5.19K
Gross Profit
1.31M 1.23M 922.91K 251.13K -280.02K -301.75K -370.93K -140.96K 34.16K -1.44K 200.92K 193.69K 178.72K 90.03K 82.92K 58.01K 33.23K
Operating Income
-24.16M -27.02M -29.98M -32.77M -35.33M -35.99M -35.26M -34.6M -33.15M -31.78M -32.55M -32.12M -29.92M -28.33M -25.21M -22.15M -21.46M
Interest Income
1.45K 9.95K 17.97K 17.67K 44.33K 93.32K 152.14K 198.86K 182.91K 125.27K 58.34K 11.68K 1.01K 2.73K 3.04K 5.55K 12.8K
Pretax Income
-24.26M -27.26M -30.2M -32.79M -35.28M -35.68M -34.21M -33.57M -31.75M -30.6M -31.37M -30.74M -28.58M -26.99M -24.04M -21.2M -20.67M
Net Income
-24.02M -26.97M -29.87M -32.42M -34.91M -35.32M -33.86M -33.24M -31.41M -30.27M -31.06M -30.46M -28.33M -26.81M -23.92M -21.11M -20.62M
Selling & General & Admin
12.98M 13.69M 14.73M 15.95M 16.57M 16.92M 16.74M 16.56M 17.07M 16.93M 17.93M 17.13M 14.62M 12.75M 9.24M 7.4M 6.83M
Research & Development
12.38M 14.41M 16M 17.18M 18.91M 19.19M 18.97M 18.32M 16.15M 14.84M 14.45M 14.89M 15.26M 15.54M 15.93M 14.67M 14.51M
Other Expenses
-221.82K -221.82K -179.59K -179.59K 93.83K 165.79K -613.78K -613.78K -899.4K -840.44K -834.04K -1.22M -1.29M -1.39M -1.23M -788.44K -465.16K
Operating Expenses
24.82M 27.29M 30.26M 32.69M 35.39M 36.35M 35.2M 34.28M 32.26M 30.86M 31.48M 30.79M 28.58M 26.9M 23.94M 21.28M 20.87M
Interest Expense
359.8K 340.36K 305.87K 270.39K 247.53K 221.62K 220.85K 204.57K 183.38K 173.09K 151.03K 152.09K 154.65K 155.8K 159.33K 155.28K 138.2K
Selling & Marketing Expenses
2.35M 1.68M 1.84M 946.32K 1.04M 1.01M 911.82K 965.1K 2.48M 3.86M 6.11M 6.62M 5.3M 4.13M 1.94M 1.47M 1.23M
Cost & Expenses
25.47M 28.26M 31.27M 33.7M 36.08M 36.71M 35.2M 34.28M 32.26M 30.86M 31.48M 30.79M 28.58M 26.9M 23.94M 21.28M 20.87M
Income Tax Expense
n/a n/a n/a -28.91K -50.88K -50.88K -50.88K -21.98K n/a n/a -73.09K -118.15K -139.53K -148.95K -99.36K -54.3K -32.92K
Shares Outstanding (Basic)
96.54M 86.53M 87.89M 82.67M 81.96M 81.17M 78.18M 66.88M 60.18M 57.87M 56.12M 53.81M 53.78M 53.17M 53.17M 52.95M 50.93M
Shares Outstanding (Diluted)
96.54M 86.53M 87.89M 82.67M 81.96M 81.17M 78.18M 66.88M 60.18M 57.87M 56.12M 53.81M 53.78M 53.17M 53.17M 52.95M 50.93M
EPS (Basic)
-0.28 -0.32 -0.36 -0.4 -0.46 -0.51 -0.53 -0.56 -0.56 -0.55 -0.57 -0.56 -0.52 -0.5 -0.46 -0.42 -0.44
EPS (Diluted)
-0.28 -0.32 -0.36 -0.4 -0.46 -0.51 -0.53 -0.56 -0.56 -0.55 -0.57 -0.56 -0.52 -0.5 -0.45 -0.41 -0.43
EBITDA
-22.61M -25.62M -28.55M -31.14M -33.63M -34.04M -32.64M -32.08M -30.34M -29.24M -30.05M -29.43M -27.27M -25.69M -22.71M -19.91M -19.36M
EBIT
-23.9M -26.92M -29.89M -32.51M -35.03M -35.46M -33.99M -33.37M -31.57M -30.43M -31.22M -30.59M -28.43M -26.83M -23.88M -21.04M -20.53M
Depreciation & Amortization
1.33M 1.34M 1.35M 1.37M 1.4M 1.41M 1.36M 1.29M 1.23M 1.19M 1.17M 1.16M 1.16M 1.15M 1.18M 1.13M 1.08M